Nevro Corp
(NVRO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2013 | 12-2012 | |
| Sales | 6,198 | 0 |
| Cost of Goods | 2,470 | N/A |
| Gross Profit | 3,728 | N/A |
| Operating Expenses | 9,560 | 0 |
| Operating Income | -5,362 | N/A |
| Other Income | 477 | 0 |
| Pre-tax Income | -4,885 | 0 |
| Income Tax | 131 | N/A |
| Net Income Continuous | -5,016 | N/A |
| Net Income | $-5,016 | $N/A |
| EPS Basic Total Ops | -5.54 | N/A |
| EPS Basic Continuous Ops | -5.49 | N/A |
| EPS Diluted Total Ops | -5.54 | N/A |
| EPS Diluted Continuous Ops | -5.49 | N/A |
| EBITDA(a) | $-5,362 | $N/A |